期刊文献+

原发中枢神经系统淋巴瘤的MRI特点及其在脑组织活检中的应用 被引量:14

The MRI features of central nervous system lymphoma (PCNSL) and its implications in the biopsy.
下载PDF
导出
摘要 目的探讨原发性中枢神经系统淋巴瘤(primary central nervous system lymphoma,PCNSL)的MRI成像病灶部位、大小、数目以及强化的特点。方法回顾分析2000年1月至2008年12月期间在中山大学附属肿瘤医院和附属第一医院住院,经病理证实的35例PCNSL患者的MRI表现。记录MRI上病灶的部位、大小、数目、强化特点、瘤周水肿大小、胼胝体有无受累等表现。结果35例患者共检出51个病灶,其中26例患者为单发,9例患者为多发。病灶从1个到5个,最多见的部位是大脑半球(52.9%),其次依次为基底节-丘脑区域(17.7%),所有病灶均表现有强化,但强化的程度有所不同,均匀强化的病灶有34个,不均匀强化的病灶有17个。瘤周水肿1级14个,2级31个,3级6个。35例患者中6例表现有胼胝体受累及。35例中有9例是经立体定向活检病理诊断,取材部位均为强化处或病灶边缘。结论PCNSL多数位于大脑半球,有占位效应,MRI成像强化明显,直径多大于20mm,侵犯胼胝体的病灶体积更大。MRI成像病灶强化明显或者病灶的边缘部位是立体定向脑活检的最佳部位。 Objective To characterize the MRI findings of primary central nervous system lymphoma (PCNSL) in immunocompetent patients. Methods The MRI brain imaging of Patients with pathological proved PCNSL were analyzed retrospectively. From Jan 2000 to Dee 2008, 35 patients were admitted into the cancer center and the first affiliated hospital of Sun Yat-sen University. Locations, sizes, numbers, enhancement characteristics of lesions, edema around the tumor and involvement of the corpus callosum on MRI were recorded and analyzed. Results Fifty-one lesions were found in 35 patients. The number of lesions ranged from 1 ( n = 26) to 5 ( n = 9) with a mean of 1.7. The most frequent locations were the cerebral hemispheres ( 27/51,52.9 % ), basal ganglia-thalamus (9/51,17.7% ) and corpus eallosum ( 8/51,15.7 % ). Contrast enhancement was found in all patients. Among them, 34 lesions exhibited homogeneous enhancement pattern and 17 lesions had inhomogeneous enhancement pattern. First, second and third levels of peritumoral edema were found in 14, 31 and 6 lesions, respectively. Nine patients were diagnosed by stereotaxis biopsy at contrast enhanced lesion site or the margin of the tumor. Conclusions The cerebral hemisphere is the commonest location of PCNSL. MRI features of PCNSL are mass, contrast-enhancing lesions with a diameter of at least 20 ram. The margin of lesion or the location with greatest contrast-enhancement would be the best site for biopsy.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2009年第8期472-475,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 原发性中枢神经系统淋巴瘤 磁共振成像 立体定向活检 Primary central nervous system lymphoma (PCNSL) MRI Stereotaxis biopsy
  • 相关文献

参考文献15

  • 1杨学军.解读《世界卫生组织中枢神经系统肿瘤分类(2007年)》[J].中国神经精神疾病杂志,2007,33(9):513-517. 被引量:115
  • 2Salvesen HI, Aarseth JH, Hollender A, et al. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway[ J ]. Acta Oncol, 2004, 43 (6) : 520 - 529.
  • 3Corn BJ, Marens S, Tophom A, et al. Will primary central nervous sys2 tern lymphoma be the most freguent brain tumor in the year 2000 [ J ]. Cancer, 1997, 79 (10) : 2409 - 2412.
  • 4于同刚,戴嘉中,冯晓源.原发性中枢神经系统淋巴瘤的MRI及^1H-MRS特点[J].临床放射学杂志,2005,24(8):668-672. 被引量:64
  • 5王进钢,黄文辉,胡滨.立体定向脑活检术58例经验总结[J].中国微侵袭神经外科杂志,2004,9(10):462-463. 被引量:4
  • 6余剑,陈向燕,范玉华,赵湛,崔春梅,黄如训,曾进胜.免疫功能正常的原发性中枢神经系统淋巴瘤22例临床病理分析[J].中国神经精神疾病杂志,2004,30(1):27-29. 被引量:5
  • 7Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases[ J]. J Neurosurg, 2000, 92 (2) : 261 -266.
  • 8Shenkier TN, Voss N, Chhanabhai M, et al. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients[J]. Cancer, 2005,103(5) : 1008 - 1017.
  • 9Buhring U, Herrlinger U, Krings T, et al. MRI features of primary central nervous system lymphomas (PCNSL) at presentation [ J ]. Neurology,2001, 57 ( 3 ) : 393 - 396.
  • 10Kuker W, Nugele T, Korfel A, et al. Primary central nervous system lymphomas (PCNSL) : MRI features at presentation in 100 patients[J]. J Neurooncol, 2005, 72(2) : 169 -177.

二级参考文献38

  • 1[1]Nasir S, DeAngelis LM. Update on the management of primary CNS lymphonuc. Oncology(Huntingt), 2000, 14(2): 228.
  • 2[2]National Cancer Institute. The non-Hodgkin's lymphoma pathologic classification project: NCI sponsored study of classification of non-Hodgkin's lymphoma: summary and description of a working formulation for clinical usage. Cancer, 1982, 49(10): 2112.
  • 3[3]Plasswilm L, Herrlinger U, Korfel A, et al. Primary central nervous system (CNS) lymphoma in irnmunocompetent patients. Ann Hematol,2002, 81(8):415.
  • 4[4]McAllister LD. Primary central nervous system lymphoma: a review. Curr Neurol Neurosci Rep, 2002, 2(3): 210.
  • 5[5]Basso U, Brandes AA. Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma. Eur J Cancer, 2002,38(10): 1298.
  • 6[6]Herrlinger U, Schabet M, Bitzer M, et al. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooneol,1999, 43(3) :219.
  • 7[7]Herrlinger U. Primary CNS lymphoma: findings outside the brain. J Neurooncol, 1999, 43(3): 227.
  • 8[8]DeAngelis LM. Primary central nervous system lymphoma [ editorial]. J Neurol Neurosurg Psychiatry, 1999, 66(6): 699.
  • 9[9]Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol,1999,43(3): 199.
  • 10[10]Buhring U, Herrlinger U, Kfings T, et al. MRI features of primary central nervous system lymphomas at presentation. Neurology, 2001, 57(3): 393.

共引文献181

同被引文献122

引证文献14

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部